Literature DB >> 26865198

Medication Adherence and the Risk of Cardiovascular Mortality and Hospitalization Among Patients With Newly Prescribed Antihypertensive Medications.

Soyeun Kim1, Dong Wook Shin1, Jae Moon Yun1, Yunji Hwang1, Sue K Park1, Young-Jin Ko1, BeLong Cho2.   

Abstract

The importance of adherence to antihypertensive treatments for the prevention of cardiovascular disease has not been well elucidated. This study evaluated the effect of antihypertensive medication adherence on specific cardiovascular disease mortality (ischemic heart disease [IHD], cerebral hemorrhage, and cerebral infarction). Our study used data from a 3% sample cohort that was randomly extracted from enrollees of Korean National Health Insurance. Study subjects were aged ≥20 years, were diagnosed with hypertension, and started newly prescribed antihypertensive medication in 2003 to 2004. Adherence to antihypertensive medication was estimated as the cumulative medication adherence. Subjects were divided into good (cumulative medication adherence, ≥80%), intermediate (cumulative medication adherence, 50%-80%), and poor (cumulative medication adherence, <50%) adherence groups. We used time-dependent Cox proportional hazards models to evaluate the association between medication adherence and health outcomes. Among 33 728 eligible subjects, 670 (1.99%) died of coronary heart disease or stroke during follow-up. Patients with poor medication adherence had worse mortality from IHD (hazard ratio, 1.64; 95% confidence interval, 1.16-2.31; P for trend=0.005), cerebral hemorrhage (hazard ratio, 2.19; 95% confidence interval, 1.28-3.77; P for trend=0.004), and cerebral infarction (hazard ratio, 1.92; 95% confidence interval, 1.25-2.96; P for trend=0.003) than those with good adherence. The estimated hazard ratios of hospitalization for cardiovascular disease were consistent with the mortality end point. Poor medication adherence was associated with higher mortality and a greater risk of hospitalization for specific cardiovascular diseases, emphasizing the importance of a monitoring system and strategies to improve medication adherence in clinical practice.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  antihypertensive agents; cerebral hemorrhage; hospitalization; medication adherence; stroke

Mesh:

Substances:

Year:  2016        PMID: 26865198     DOI: 10.1161/HYPERTENSIONAHA.115.06731

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  48 in total

1.  Socioeconomic, Psychosocial and Behavioral Characteristics of Patients Hospitalized With Cardiovascular Disease.

Authors:  Matthew E Dupre; Alicia Nelson; Scott M Lynch; Bradi B Granger; Hanzhang Xu; Erik Churchill; Janese M Willis; Lesley H Curtis; Eric D Peterson
Journal:  Am J Med Sci       Date:  2017-07-25       Impact factor: 2.378

Review 2.  Improving Medication Adherence in Coronary Heart Disease.

Authors:  Leah L Zullig; Katherine Ramos; Hayden B Bosworth
Journal:  Curr Cardiol Rep       Date:  2017-09-22       Impact factor: 2.931

3.  Association between adherence to antihypertensive medications and health outcomes in middle and older aged community dwelling adults; results from the Irish longitudinal study on ageing.

Authors:  Caroline A Walsh; Caitriona Cahir; Kathleen E Bennett
Journal:  Eur J Clin Pharmacol       Date:  2019-06-12       Impact factor: 2.953

4.  Antihypertensive Adherence Trajectories Among Older Adults in the First Year After Initiation of Therapy.

Authors:  Jennifer L Hargrove; Virginia Pate; Carri H Casteel; Yvonne M Golightly; Laura R Loehr; Stephen W Marshall; Til Stürmer
Journal:  Am J Hypertens       Date:  2017-10-01       Impact factor: 2.689

5.  Clinical efficacy of aspirin with identification of intimal morphology by optical coherence tomography in preventing event recurrence in patients with vasospasm-induced acute coronary syndrome.

Authors:  Yonggu Lee; Hwan-Cheol Park; Jinho Shin
Journal:  Int J Cardiovasc Imaging       Date:  2018-06-19       Impact factor: 2.357

6.  Adherence to antihypertensive medication and its predictors among non-elderly adults in Japan.

Authors:  Shiori Nishimura; Hiraku Kumamaru; Satoshi Shoji; Mitsuaki Sawano; Shun Kohsaka; Hiroaki Miyata
Journal:  Hypertens Res       Date:  2020-04-20       Impact factor: 3.872

7.  Sodium Intake Reduction in Real World.

Authors:  Moo Yong Rhee
Journal:  Korean Circ J       Date:  2020-02-26       Impact factor: 3.243

8.  Adherence to Adjuvant Endocrine Therapy in Insured Black and White Breast Cancer Survivors: Exploring Adherence Measures in Patient Data.

Authors:  Vanessa B Sheppard; Jun He; Arnethea Sutton; Lee Cromwell; Georges Adunlin; Teresa M Salgado; Dennis Tolsma; Martha Trout; Brandi E Robinson; Megan C Edmonds; Hayden B Bosworth; Mahlet G Tadesse
Journal:  J Manag Care Spec Pharm       Date:  2019-05

9.  Fixed-dose combinations: A valuable tool to improve adherence to antihypertensive treatment.

Authors:  Sarantis Satsoglou; Konstantinos Tziomalos
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-04-27       Impact factor: 3.738

10.  Psychometric properties of medication adherence instruments in cardiovascular diseases and type 2 diabetes mellitus: systematic review protocol.

Authors:  Henrique Ceretta Oliveira; Daisuke Hayashi Neto; Samantha Dalbosco Lins Carvalho; Rita de Cássia Lopes Barros; Mayza Luzia Dos Santos Neves; Carla Renata Silva Andrechuk; Neusa Maria Costa Alexandre; Roberta Cunha Matheus Rodrigues
Journal:  Syst Rev       Date:  2021-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.